OHSU in the news

New equity-driven crisis care principles to support surge planning

Oregon Health Authority December 08, 2020
Robert Macauley, M.D. comments on The Oregon Health Authority’s efforts to update its guidance for promoting health equity during resource constrained events. He says: “OHA’s commitment to developing principles to ensure all Oregonians — particularly communities of color, tribal communities and people with disabilities — have the resources they need is an important next step.”

Higher risk of exposure, not underlying conditions, found to be cause of disproportionate impact of coronavirus on minority populations, study says

The Oregonian December 08, 2020
A systematic review led by researchers at OHSU and the VA Portland Health Care System finds that Black and Hispanic populations are disproportionately affected by COVID-19. Devan Kansagara, M.D. says: “The information we've seen so far suggests the disparities were likely related to exposure-related factors rather than other factors, like underlying health issues.”

Oregon dentists training to give vaccine shots

KOIN-TV December 07, 2020
Mary Pat Califano, R.N., speaks about OHSU’s dental vaccination training program, which – so far - has trained more than 200 Oregon dentists who could help to deliver COVID vaccines when they become available. She says: “To help not only improve the immunization rates in Oregon, but potentially help in this pandemic is huge.”

'We're exhausted': Local nurse shares toll of COVID-19 pandemic

KPTV December 07, 2020
Grace Bradley, R.N., shares the toll of caring for COVID patients, saying “I’ll leave these shifts so dehydrated because you get so in the zone and you’re taking care of this patients and you’re doing the work of three or four people, if you can, because you’re putting their needs above your own.”

What you need to know about COVID-19 vaccine coming to Oregon

OPB December 05, 2020
In a story explaining the leading COVID vaccine candidates and how some could be distributed soon, Marcel Curlin, M.D., explains why it’s important to have more than one candidate: “If you have four vaccine products that are showing good efficacy, and we find out that one of the vaccines doesn’t particularly work well in elderly populations, one of the other three might.” And Mark Slifka, Ph.D., notes the candidates are undergoing the same rigorous scientific processes of other vaccines, albeit in an accelerate fashion.
See more stories